ID   REME011-2
AC   CVCL_E3Q4
SY   REME011; REME11-2; REME11; F_PDO_000063
DR   CancerTools; 160911
RX   PubMed=29917168;
WW   https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
CC   Group: Organoid.
CC   Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
CC   Population: Japanese.
CC   Doubling time: ~8 days (PubMed=29917168).
CC   Omics: Deep exome analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C8028; Endometrial clear cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   PubMed=29917168; DOI=10.3892/or.2018.6501; PMCID=PMC6072291;
RA   Tamura H., Higa A., Hoshi H., Hiyama G., Takahashi N., Ryufuku M.,
RA   Morisawa G., Yanagisawa Y., Ito E., Imai J.-i., Dobashi Y., Katahira K.,
RA   Soeda S., Watanabe T., Fujimori K., Watanabe S., Takagi M.;
RT   "Evaluation of anticancer agents using patient-derived tumor organoids
RT   characteristically similar to source tissues.";
RL   Oncol. Rep. 40:635-646(2018).
//